Biotech Stock Roundup: Horizon to Buy Hyperion, Conatus Up on …

Once again, acquisition news made it to the headlines with Horizon Pharma (HZNP – Snapshot Report) announcing that it will be acquiring Hyperion Therapeutics (HPTX – Snapshot Report). BioMarin has hit a 52-week high on acquisition rumors. Meanwhile, it’s been an eventful week on the pipeline and regulatory front as well with companies like Conatus (CNAT – Snapshot Report), Amgen […]